NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Dec 04, 2019 $0.755 $0.780 $0.691 $0.770 17 239
Dec 03, 2019 $0.86 $0.90 $0.740 $0.780 21 283
Dec 02, 2019 $0.97 $1.02 $0.760 $0.85 112 332
Nov 29, 2019 $0.88 $0.97 $0.83 $0.97 21 222
Nov 27, 2019 $0.91 $0.94 $0.751 $0.88 160 059
Nov 26, 2019 $0.710 $1.19 $0.680 $0.94 1 201 201
Nov 25, 2019 $0.500 $0.640 $0.500 $0.637 93 296
Nov 22, 2019 $0.519 $0.530 $0.500 $0.530 13 950
Nov 21, 2019 $0.570 $0.570 $0.500 $0.522 17 284
Nov 20, 2019 $0.570 $0.580 $0.540 $0.540 16 893
Nov 19, 2019 $0.550 $0.580 $0.545 $0.555 3 281
Nov 18, 2019 $0.500 $0.580 $0.500 $0.519 11 031
Nov 15, 2019 $0.580 $0.620 $0.514 $0.514 19 259
Nov 14, 2019 $0.594 $0.597 $0.569 $0.569 14 502
Nov 13, 2019 $0.600 $0.621 $0.600 $0.600 8 850
Nov 12, 2019 $0.643 $0.643 $0.620 $0.630 3 193
Nov 11, 2019 $0.650 $0.659 $0.650 $0.659 1 584
Nov 08, 2019 $0.620 $0.650 $0.620 $0.650 3 544
Nov 07, 2019 $0.667 $0.670 $0.632 $0.632 3 143
Nov 06, 2019 $0.671 $0.679 $0.630 $0.642 10 727
Nov 05, 2019 $0.680 $0.690 $0.655 $0.655 4 159
Nov 04, 2019 $0.635 $0.695 $0.620 $0.655 6 059
Nov 01, 2019 $0.700 $0.700 $0.660 $0.668 3 713
Oct 31, 2019 $0.630 $0.698 $0.630 $0.670 3 192
Oct 30, 2019 $0.650 $0.666 $0.650 $0.660 1 598
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT